Comparison of Toxicity and Treatment Outcomes in HIV-positive Versus HIV-negative Patients With Squamous Cell Carcinoma of the Anal Canal

Conclusions: In the highly active antiretroviral therapy era, HIV-positive patients with anal cancer treated with standard definitive chemoradiation have equivalent toxicity and cancer-specific survival compared with HIV-negative patients. (Source: American Journal of Clinical Oncology)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2vZgf4J
via IFTTT